Tudor Investment Corp’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-13,742
Closed -$21K 1310
2018
Q1
$21K Hold
13,742
﹤0.01% 963
2017
Q4
$10K Hold
13,742
﹤0.01% 1063
2017
Q3
$16K Hold
13,742
﹤0.01% 1058
2017
Q2
$24K Hold
13,742
﹤0.01% 994
2017
Q1
$36K Hold
13,742
﹤0.01% 1338
2016
Q4
$58K Hold
13,742
﹤0.01% 1333
2016
Q3
$37K Hold
13,742
﹤0.01% 1380
2016
Q2
$24K Hold
13,742
﹤0.01% 1567
2016
Q1
$32K Sell
13,742
-500
-4% -$1.13K ﹤0.01% 1667
2015
Q4
$49K Sell
14,242
-940
-6% -$4.5K ﹤0.01% 1582
2015
Q3
$93K Sell
15,182
-2,488
-14% -$16.9K ﹤0.01% 1435
2015
Q2
$117K Sell
17,670
-1,792
-9% -$12.1K ﹤0.01% 1405
2015
Q1
$139K Buy
+19,462
New +$147K ﹤0.01% 1349

Other funds holding GEN

Tudor Investment Corp's GEN Position: Q2 2018 in Review

Tudor Investment Corp sold out of Genesis Healthcare, Inc. (GEN) in Q2 2018, closing a stake of 13,742 shares — an estimated $21K sold.

Tudor Investment Corp first reported a position in GEN in Q1 2015 and held it in 13 quarters. The position peaked at $139K in Q1 2015. 82 funds tracked by Wall St. Rank hold GEN as of Q2 2018.

  • Tudor Investment Corp reported no remaining Genesis Healthcare, Inc. position as of Q2 2018 after selling out during the quarter.
  • Tudor Investment Corp sold 13,742 Genesis Healthcare, Inc. shares in Q2 2018, an estimated $21K.
  • Tudor Investment Corp first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 13 quarters.
  • Tudor Investment Corp's Genesis Healthcare, Inc. position peaked at $139K in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2018.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.